Donoghue Forlines LLC Moderna, Inc. Transaction History

Donoghue Forlines LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $80,702 - $121,670	-689 Reduced 13.59%	4,382 $626,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $641,278 - $1.19 Million	5,071 New	5,071 $874,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $474,447 - $774,239	-2,101 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $48,596 - $106,098	219 Added 11.64%	2,101 $809,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $657,994 - $1.19 Million	-5,065 Reduced 72.91%	1,882 $442,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $906,084 - $1.54 Million	-8,299 Reduced 54.43%	6,947 $910,000
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $1 Million - $2.59 Million	15,246 New	15,246 $1.59 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $1.18 Million - $2.07 Million	-21,795 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $646,657 - $1.74 Million	21,795 New	21,795 $1.4 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.